{"id":68308,"date":"2025-03-03T15:07:34","date_gmt":"2025-03-03T15:07:34","guid":{"rendered":"https:\/\/leitat.org\/blog\/leitat-visita-les-installacions-doncomatryx-en-el-marc-del-projecte-nextom\/"},"modified":"2025-05-13T10:24:50","modified_gmt":"2025-05-13T10:24:50","slug":"leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project","status":"publish","type":"post","link":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/","title":{"rendered":"Leitat visits ONCOMATRYX&#8217;s facilities as part of the NEXTOM project"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"68308\" class=\"elementor elementor-68308 elementor-68297\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-259edf9 e-flex e-con-boxed e-con e-parent\" data-id=\"259edf9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fd88bdc elementor-widget elementor-widget-text-editor\" data-id=\"fd88bdc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The biopharmaceutical company ONCOMATRYX Biopharma and Leitat are collaborating in the NEXTOM project, which aims to develop new Antibody Drug Conjugates (ADCs) targeting the tumor microenvironment. This approach represents a novel strategy in oncology to improve the effectiveness of current cancer treatments, particularly in their most invasive and metastatic stages. ADCs are an emerging class of highly potent pharmaceutical compounds that offer an innovative combination of chemotherapy and immunotherapy.<\/p><p>Through this project, ONCOMATRYX will be able to obtain new ADCs to enhance the efficacy of immuno-oncological treatments in their most aggressive stages. Leitat, in turn, will expand its portfolio of animal models in oncology and contribute its expertise in preclinical and bioanalytical development. By the end of the NEXTOM project, the best ADC therapeutic candidate will be selected to continue with industrial and clinical development.<\/p><p>As part of the NEXTOM project, a first in-person meeting was held on February 5 at ONCOMATRYX&#8217;s facilities, where the project status was updated and the next steps were defined to achieve the objectives set.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>The biopharmaceutical company ONCOMATRYX Biopharma and Leitat are collaborating in the NEXTOM project, which aims to develop new Antibody Drug Conjugates (ADCs) targeting the tumor microenvironment. This approach represents a novel strategy in oncology to improve the effectiveness of current cancer treatments, particularly in their most invasive and metastatic stages. ADCs are an emerging class [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":68299,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[142],"tags":[208],"class_list":["post-68308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-technologies-en","tag-blog-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Leitat visits ONCOMATRYX&#039;s facilities as part of the NEXTOM project - Leitat Technological Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leitat visits ONCOMATRYX&#039;s facilities as part of the NEXTOM project - Leitat Technological Center\" \/>\n<meta property=\"og:description\" content=\"The biopharmaceutical company ONCOMATRYX Biopharma and Leitat are collaborating in the NEXTOM project, which aims to develop new Antibody Drug Conjugates (ADCs) targeting the tumor microenvironment. This approach represents a novel strategy in oncology to improve the effectiveness of current cancer treatments, particularly in their most invasive and metastatic stages. ADCs are an emerging class [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/\" \/>\n<meta property=\"og:site_name\" content=\"Leitat Technological Center\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T15:07:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-13T10:24:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Dissemination Manager\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dissemination Manager\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/\"},\"author\":{\"name\":\"Dissemination Manager\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2\"},\"headline\":\"Leitat visits ONCOMATRYX&#8217;s facilities as part of the NEXTOM project\",\"datePublished\":\"2025-03-03T15:07:34+00:00\",\"dateModified\":\"2025-05-13T10:24:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/\"},\"wordCount\":181,\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png\",\"keywords\":[\"Blog News\"],\"articleSection\":[\"Health technologies\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/\",\"url\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/\",\"name\":\"Leitat visits ONCOMATRYX's facilities as part of the NEXTOM project - Leitat Technological Center\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png\",\"datePublished\":\"2025-03-03T15:07:34+00:00\",\"dateModified\":\"2025-05-13T10:24:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png\",\"width\":1200,\"height\":1600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"HOME\",\"item\":\"https:\/\/leitat.org\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Health technologies\",\"item\":\"https:\/\/leitat.org\/en\/blog\/category\/health-technologies-en\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Leitat visits ONCOMATRYX&#8217;s facilities as part of the NEXTOM project\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leitat.org\/en\/#website\",\"url\":\"https:\/\/leitat.org\/en\/\",\"name\":\"Leitat Technological Center\",\"description\":\"Managing Technologies\",\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leitat.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leitat.org\/en\/#organization\",\"name\":\"Leitat Technological Center\",\"url\":\"https:\/\/leitat.org\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"width\":226,\"height\":78,\"caption\":\"Leitat Technological Center\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2\",\"name\":\"Dissemination Manager\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"caption\":\"Dissemination Manager\"},\"sameAs\":[\"https:\/\/leitat.org\"],\"url\":\"https:\/\/leitat.org\/en\/blog\/author\/editor-wp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leitat visits ONCOMATRYX's facilities as part of the NEXTOM project - Leitat Technological Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Leitat visits ONCOMATRYX's facilities as part of the NEXTOM project - Leitat Technological Center","og_description":"The biopharmaceutical company ONCOMATRYX Biopharma and Leitat are collaborating in the NEXTOM project, which aims to develop new Antibody Drug Conjugates (ADCs) targeting the tumor microenvironment. This approach represents a novel strategy in oncology to improve the effectiveness of current cancer treatments, particularly in their most invasive and metastatic stages. ADCs are an emerging class [&hellip;]","og_url":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/","og_site_name":"Leitat Technological Center","article_published_time":"2025-03-03T15:07:34+00:00","article_modified_time":"2025-05-13T10:24:50+00:00","og_image":[{"width":1200,"height":1600,"url":"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png","type":"image\/png"}],"author":"Dissemination Manager","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dissemination Manager","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#article","isPartOf":{"@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/"},"author":{"name":"Dissemination Manager","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2"},"headline":"Leitat visits ONCOMATRYX&#8217;s facilities as part of the NEXTOM project","datePublished":"2025-03-03T15:07:34+00:00","dateModified":"2025-05-13T10:24:50+00:00","mainEntityOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/"},"wordCount":181,"publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png","keywords":["Blog News"],"articleSection":["Health technologies"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/","url":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/","name":"Leitat visits ONCOMATRYX's facilities as part of the NEXTOM project - Leitat Technological Center","isPartOf":{"@id":"https:\/\/leitat.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png","datePublished":"2025-03-03T15:07:34+00:00","dateModified":"2025-05-13T10:24:50+00:00","breadcrumb":{"@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#primaryimage","url":"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2025\/03\/Diseno-sin-titulo-2.png","width":1200,"height":1600},{"@type":"BreadcrumbList","@id":"https:\/\/leitat.org\/en\/blog\/leitat-visits-oncomatryxs-facilities-as-part-of-the-nextom-project\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"HOME","item":"https:\/\/leitat.org\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Health technologies","item":"https:\/\/leitat.org\/en\/blog\/category\/health-technologies-en\/"},{"@type":"ListItem","position":3,"name":"Leitat visits ONCOMATRYX&#8217;s facilities as part of the NEXTOM project"}]},{"@type":"WebSite","@id":"https:\/\/leitat.org\/en\/#website","url":"https:\/\/leitat.org\/en\/","name":"Leitat Technological Center","description":"Managing Technologies","publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leitat.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leitat.org\/en\/#organization","name":"Leitat Technological Center","url":"https:\/\/leitat.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","width":226,"height":78,"caption":"Leitat Technological Center"},"image":{"@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2","name":"Dissemination Manager","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","caption":"Dissemination Manager"},"sameAs":["https:\/\/leitat.org"],"url":"https:\/\/leitat.org\/en\/blog\/author\/editor-wp\/"}]}},"_links":{"self":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/68308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/comments?post=68308"}],"version-history":[{"count":14,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/68308\/revisions"}],"predecessor-version":[{"id":70097,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/68308\/revisions\/70097"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media\/68299"}],"wp:attachment":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media?parent=68308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/categories?post=68308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/tags?post=68308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}